skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)

Journal Article · · European Journal of Medicinal Chemistry

Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER); USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
KP1605010; 10RR024664; AC02-06CH11357; SC0012704; S10OD030394
OSTI ID:
1970422
Journal Information:
European Journal of Medicinal Chemistry, Journal Name: European Journal of Medicinal Chemistry Vol. 254 Journal Issue: C; ISSN 0223-5234
Publisher:
ElsevierCopyright Statement
Country of Publication:
France
Language:
English

References (73)

Linking Crystallographic Model and Data Quality journal May 2012
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants journal March 2021
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19 journal March 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination journal June 2022
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors journal April 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies journal December 2021
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir journal July 2022
Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors journal January 2013
Developments in the CCP 4 molecular-graphics project journal November 2004
Current status of therapeutic monoclonal antibodies against SARS-CoV-2 journal September 2021
Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease journal July 2017
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity journal December 2021
The biological and clinical significance of emerging SARS-CoV-2 variants journal September 2021
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2 journal October 2021
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses journal August 2012
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection journal July 2021
Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2 journal November 2022
Tetrabutylammonium bisulfate: a new effective catalyst for the hydrolysis of aziridines or epoxides journal April 2003
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19 journal October 2022
A new coronavirus associated with human respiratory disease in China journal February 2020
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications journal May 2021
A Novel, Nonaqueous Method for Regeneration of Aldehydes from Bisulfite Adducts journal July 1999
The Synthesis of Aminoazole Analogs of Lysine and Arginine: The Mitsunobu Reaction with Lysinol and Argininol journal August 1999
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid journal September 2005
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis journal May 2017
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability journal July 2021
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease journal September 2022
Scaling and assessment of data quality journal December 2005
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease journal April 2020
XDS journal January 2010
X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation journal September 2022
Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease journal August 2021
Global indicators of X-ray data quality journal April 2001
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors journal April 2020
SARS-CoV-2 Vaccines journal April 2021
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2 journal April 2021
Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors journal September 2021
Applications of Deuterium in Medicinal Chemistry journal January 2019
Perspectives on SARS-CoV-2 Main Protease Inhibitors journal November 2021
Improved R-factors for diffraction data analysis in macromolecular crystallography journal April 1997
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies journal September 2021
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities journal March 2021
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography journal June 2020
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron journal January 2022
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors journal March 2020
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 journal October 2021
Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies journal December 2022
Features and development of Coot journal March 2010
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L journal November 2021
Natural-Products-Inspired Use of the gem -Dimethyl Group in Medicinal Chemistry journal August 2017
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing journal March 2021
Resolving Some Old Problems in Protein Crystallography journal May 2012
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 journal December 2021
An introduction to data reduction: space-group determination, scaling and intensity statistics journal March 2011
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL pro ) journal August 2021
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor α Agonists journal September 2009
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors journal December 2022
SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model journal February 2021
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease journal July 2021
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease journal May 2022
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron journal April 2022
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine journal May 2022
COVID-19: Drug Targets and Potential Treatments journal June 2020
Data processing and analysis with the autoPROC toolbox journal March 2011
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies journal August 2020
Conservation of substrate specificities among coronavirus main proteases journal March 2002
Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors journal March 2021
Automatic indexing of rotation diffraction patterns journal February 1988
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease journal August 2021
Phaser crystallographic software journal July 2007
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L journal November 2020